Free Trial

Gentex Corporation (NASDAQ:GNTX) Given Consensus Rating of "Hold" by Analysts

Gentex logo with Auto/Tires/Trucks background
Image from MarketBeat Media, LLC.

Key Points

  • Gentex (NASDAQ: GNTX) has a consensus analyst rating of Hold from eight firms (six hold, two buy) with an average 12‑month price target of $26.71.
  • In its most recent quarter Gentex reported EPS of $0.44, beating estimates by $0.01, and revenue of $644.4M (up 19% year‑over‑year) though slightly below analyst expectations; analysts forecast about $2.04 EPS for the fiscal year.
  • The company declared a quarterly dividend of $0.12 (annualized $0.48, ~2.2% yield), while insiders—including the CFO and CTO—sold a combined 58,133 shares (~$1.44M) over the last quarter.
  • Five stocks we like better than Gentex.

Shares of Gentex Corporation (NASDAQ:GNTX - Get Free Report) have received a consensus rating of "Hold" from the eight research firms that are currently covering the stock, Marketbeat.com reports. Six analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $26.7143.

Several research analysts recently weighed in on the stock. UBS Group set a $25.00 price objective on shares of Gentex in a research report on Monday, February 2nd. Robert W. Baird set a $26.00 price target on shares of Gentex in a research note on Wednesday, January 14th. Weiss Ratings restated a "hold (c)" rating on shares of Gentex in a research report on Thursday, January 22nd. B. Riley Financial cut their target price on shares of Gentex from $32.00 to $28.00 and set a "buy" rating for the company in a research report on Monday, February 2nd. Finally, Wall Street Zen downgraded Gentex from a "buy" rating to a "hold" rating in a research report on Saturday, February 28th.

Check Out Our Latest Research Report on GNTX

Gentex Stock Performance

NASDAQ:GNTX opened at $22.08 on Friday. The firm has a market capitalization of $4.76 billion, a price-to-earnings ratio of 12.69 and a beta of 0.76. Gentex has a 52-week low of $20.28 and a 52-week high of $29.38. The stock has a fifty day moving average of $23.85 and a 200 day moving average of $24.91.

Gentex (NASDAQ:GNTX - Get Free Report) last announced its earnings results on Friday, January 30th. The auto parts company reported $0.44 earnings per share for the quarter, topping analysts' consensus estimates of $0.43 by $0.01. Gentex had a return on equity of 16.05% and a net margin of 15.19%.The business had revenue of $644.40 million for the quarter, compared to analyst estimates of $650.90 million. During the same period in the prior year, the company earned $0.39 EPS. The company's quarterly revenue was up 19.0% compared to the same quarter last year. Equities analysts forecast that Gentex will post 2.04 earnings per share for the current fiscal year.

Gentex Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 22nd. Investors of record on Wednesday, April 8th will be given a $0.12 dividend. The ex-dividend date is Wednesday, April 8th. This represents a $0.48 dividend on an annualized basis and a yield of 2.2%. Gentex's payout ratio is presently 27.59%.

Insiders Place Their Bets

In other news, CFO Kevin C. Nash sold 11,885 shares of the company's stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $24.98, for a total value of $296,887.30. Following the completion of the sale, the chief financial officer owned 59,430 shares of the company's stock, valued at approximately $1,484,561.40. This represents a 16.67% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CTO Neil Boehm sold 11,248 shares of the stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $24.82, for a total transaction of $279,175.36. Following the transaction, the chief technology officer directly owned 58,951 shares in the company, valued at approximately $1,463,163.82. This represents a 16.02% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 58,133 shares of company stock valued at $1,442,313 over the last quarter. 0.45% of the stock is owned by corporate insiders.

Institutional Trading of Gentex

Several hedge funds have recently added to or reduced their stakes in GNTX. Addison Advisors LLC purchased a new stake in shares of Gentex during the second quarter worth about $25,000. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Gentex in the 3rd quarter worth approximately $38,000. Arax Advisory Partners bought a new stake in shares of Gentex in the 4th quarter worth approximately $52,000. Employees Retirement System of Texas purchased a new position in shares of Gentex during the fourth quarter valued at approximately $56,000. Finally, Clearstead Advisors LLC lifted its stake in Gentex by 82.3% in the third quarter. Clearstead Advisors LLC now owns 2,042 shares of the auto parts company's stock worth $58,000 after acquiring an additional 922 shares during the period. 86.76% of the stock is owned by institutional investors.

Gentex Company Profile

(Get Free Report)

Gentex Corporation NASDAQ: GNTX is a global technology company specializing in the design and manufacture of automotive and aerospace products. The company's primary business centers on automatic-dimming rearview mirrors, advanced driver-assistance systems (ADAS), and camera-based driver monitoring technologies. In the automotive sector, Gentex supplies exterior and interior mirrors with integrated electronics, connectivity features, and safety capabilities to many of the world's leading original equipment manufacturers (OEMs).

Featured Stories

Analyst Recommendations for Gentex (NASDAQ:GNTX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Gentex Right Now?

Before you consider Gentex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gentex wasn't on the list.

While Gentex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines